Treatment of two postoperative endophthalmitis cases due to Aspergillus flavus and Scopulariopsis spp. with local and systemic antifungal therapy

BMC Infectious Diseases

Volumn 7, Issue , 2007, Pages

  Aydin, Sayime ^a   Ertugrul, Bulent ^b   Gultekin, Berna ^b   Uyar, Guliz ^b   Kir, Erkin ^b  

^a DUMLUPINAR UNIVERSITY   (Turkey)

^b ADNAN MENDERES UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; CANSIDAS; CASPOFUNGIN; CEFUROXIME; CIPROFLOXACIN; GENTAMICIN; LIVER ENZYME; MEROPENEM; SILICONE OIL; STEROID; TRIAMCINOLONE; UNCLASSIFIED DRUG; VANCOMYCIN; VORICONAZOLE; ECHINOCANDIN; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; ASCOMYCETES; ASPERGILLUS FLAVUS; CACHEXIA; CASE REPORT; COLON CANCER; COLON SURGERY; DIABETIC PATIENT; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FUNGAL ENDOPHTHALMITIS; FUNGUS CULTURE; HUMAN; LENS IMPLANTATION; LOADING DRUG DOSE; MALE; MINIMUM INHIBITORY CONCENTRATION; NEPHROTOXICITY; NONHUMAN; PHACOEMULSIFICATION; POSTOPERATIVE INFECTION; RETINA MACULA DEGENERATION; SCOPULARIOPSIS; SENILE CATARACT; SIDE EFFECT; SLIT LAMP; UVEITIS; VISUAL ACUITY; VITRECTOMY; DRUG COMBINATION; DRUG EFFECT; ENDOPHTHALMITIS; MICROBIOLOGY; POSTOPERATIVE COMPLICATION; TREATMENT OUTCOME;

AGED; AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASCOMYCOTA; ASPERGILLUS FLAVUS; DRUG THERAPY, COMBINATION; ECHINOCANDINS; ENDOPHTHALMITIS; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; PYRIMIDINES; TREATMENT OUTCOME; TRIAZOLES; VITRECTOMY;

EID: 34548277416     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-7-87     Document Type: Article

References (33)

1. Read RW Endophthalmitis Ophthalmology St Louis, Mosby Inc. Yanoff M. DJS 2 2004 1152-1157
2. Benz MS Scott IU Flynn HW Jr. Unonius N Miller D Endophthalmitis isolates and antibiotic sensitivities: A 6-year review of culture-proven cases Am J Ophthalmol 2004 137 38-42 10.1016/S0002-9394(03)00896-1 14700642
3. Kunimoto DY Das T Sharma S Jalali S Majji AB Gopinathan U Athmanathan S Rao TN Microbiologic spectrum and susceptibility of isolates: Part I. Postoperative endophthalmitis. Endophthalmitis Research Group Am J Ophthalmol 1999 128 240-242 10.1016/S0002-9394(99)00112-9 10458187
4. Han DP Wisniewski SR Wilson LA Barza M Vine AK Doft BH Kelsey SF Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study Am J Ophthalmol 1996 122 1-17 8659579
5. Anand AR Therese KL Madhavan HN Spectrum of aetiological agents of postoperative endophthalmitis and antibiotic susceptibility of bacterial isolates Indian J Ophthalmol 2000 48 123-128 11116508
6. Kuriakose T Kothari M Paul P Jacob P Thomas R Intracameral amphotericin B injection in the management of deep keratomycosis Cornea 2002 21 653-656 10.1097/00003226-200210000-00004 12352080
7. Hua G Pennesi M Shah K Qiao X Hariprasad SM Mieler WF Wu SM Holz ER Safety of intravitreal voriconazole: Electroretinographic and histopathologic studies Trans Am Ophthalmol Soc 2003 101 183-9; discussion 189 1358987 14971576
8. Marangon FB Miller D Giaconi JA Alfonso EC In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens Am J Ophthalmol 2004 137 820-825 10.1016/j.ajo.2003.11.078 15126145
9. Durand ML Kim IK D'Amico DJ Loewenstein JI Tobin EH Kieval SJ Martin SS Azar DT Miller FS 3rd Lujan BJ Miller JW Successful treatment of Fusarium endophthalmitis with voriconazole and Aspergillus endophthalmitis with voriconazole plus caspofungin Am J Ophthalmol 2005 140 552-554 10.1016/j.ajo.2005.03.030 16139017
10. Breit SM Hariprasad SM Mieler WF Shah GK Mills MD Grand MG Management of endogenous fungal endophthalmitis with voriconazole and caspofungin Am J Ophthalmol 2005 139 135-140 10.1016/j.ajo.2004.08.077 15652837
11. Shrader SK Band JD Lauter CB Murphy P The clinical spectrum of endophthalmitis: Incidence, predisposing factors, and features influencing outcome J Infect Dis 1990 162 115-120 2355187
12. Kresloff MS Castellarin AA Zarbin MA Endophthalmitis Surv Ophthalmol 1998 43 193-224 10.1016/S0039-6257(98)00036-8 9862309
13. Jackson TL Eykyn SJ Graham EM Stanford MR Endogenous bacterial endophthalmitis: A 17-year prospective series and review of 267 reported cases Surv Ophthalmol 2003 48 403-423 10.1016/S0039-6257(03)00054-7 12850229
14. Binder MI Chua J Kaiser PK Procop GW Isada CM Endogenous endophthalmitis: An 18-year review of culture-positive cases at a tertiary care center Medicine (Baltimore) 2003 82 97-105 10.1097/ 00005792-200303000-00004 12640186
15. Schiedler V Scott IU Flynn HW Jr. Davis JL Benz MS Miller D Culture-proven endogenous endophthalmitis: Clinical features and visual acuity outcomes Am J Ophthalmol 2004 137 725-731 15059712
16. Narang S Gupta A Gupta V Dogra MR Ram J Pandav SS Chakrabarti A Fungal endophthalmitis following cataract surgery: Clinical presentation, microbiological spectrum, and outcome Am J Ophthalmol 2001 132 609-617 10.1016/S0002-9394(01)01180-1 11704021
17. Pettit TH Olson RJ Foos RY Martin WJ Fungal endophthalmitis following intraocular lens implantation. A surgical epidemic Arch Ophthalmol 1980 98 1025-1039 7190003
18. Fridkin SK Kremer FB Bland LA Padhye A McNeil MM Jarvis WR Acremonium kiliense endophthalmitis that occurred after cataract extraction in an ambulatory surgical center and was traced to an environmental reservoir Clin Infect Dis 1996 22 222-227 8838176
19. Essman TF Flynn HW Jr. Smiddy WE Brod RD Murray TG Davis JL Rubsamen PE Treatment outcomes in a 10-year study of endogenous fungal endophthalmitis Ophthalmic Surg Lasers 1997 28 185-194 9076791
20. Elder MJ Morlet N Endophthalmitis Clin Experiment Ophthalmol 2002 30 394-398 10.1046/j.1442-9071.2002.00567.x 12427228
21. Riddell Iv J McNeil SA Johnson TM Bradley SF Kazanjian PH Kauffman CA Endogenous Aspergillus endophthalmitis: Report of 3 cases and review of the literature Medicine (Baltimore) 2002 81 311-320 10.1097/ 00005792-200207000-00007 12169886
22. Tabbara KF al Jabarti AL Hospital construction-associated outbreak of ocular aspergillosis after cataract surgery Ophthalmology 1998 105 522-526 10.1016/S0161-6420(98)93037-8 9499785
23. Gariano RF Kalina RE Posttraumatic fungal endophthalmitis resulting from Scopulariopsis brevicaulis Retina 1997 17 256-258 10.1097/ 00006982-199717030-00015 9196940
24. Pflugfelder SC Flynn HW Jr. Zwickey TA Forster RK Tsiligianni A Culbertson WW Mandelbaum S Exogenous fungal endophthalmitis Ophthalmology 1988 95 19-30 3257818
25. McMahon MM Bistrian BR Host defenses and susceptibility to infection in patients with diabetes mellitus Infect Dis Clin North Am 1995 9 1-9 7769211
26. Leibovici L Yehezkelli Y Porter A Regev A Krauze I Harell D Influence of diabetes mellitus and glycaemic control on the characteristics and outcome of common infections Diabet Med 1996 13 457-463 10.1002/ (SICI)1096-9136(199605)13:5<457::AID-DIA83>3.0.CO;2-T 8737028
27. Eschete ML King JW West BC Oberle A Penicillium chrysogenum endophthalmitis Mycopathologia 1981 74 125-127 10.1007/BF01259468 6787430
28. Swan SK Wagner RA Myers JP Cinelli AB Mycotic endophthalmitis caused by Penicillium sp. after parenteral drug abuse Am J Ophthalmol 1985 100 408-410 4037026
29. Lyratzopoulos G Ellis M Nerringer R Denning DW Invasive infection due to penicillium species other than P. marneffei J Infect 2002 45 184-195 10.1053/jinf.2002.1056 12387776
30. Galland F le Goff L Conrath J Ridings B [Penicillium chrysogenum endophthalmitis: A case report] J Fr Ophtalmol 2004 27 264-266 15039628
31. Stevens DA Kan VL Judson MA Morrison VA Dummer S Denning DW Bennett JE Walsh TJ Patterson TF Pankey GA Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America Clin Infect Dis 2000 30 696-709 10.1086/313756 10770732
32. Arikan S Lozano-Chiu M Paetznick V Rex JH In vitro synergy of caspofungin and amphotericin B against Aspergillus and Fusarium spp Antimicrob Agents Chemother 2002 46 245-247 127002 11751145 10.1128/ AAC.46.1.245-247.2002
33. Cuenca-Estrella M Combinations of antifungal agents in therapy - what value are they? J Antimicrob Chemother 2004 54 854-869 10.1093/jac/ dkh434 15375111